Aldeyra Therapeutics
Stock Forecast, Prediction & Price Target

Aldeyra Therapeutics Financial Estimates

Aldeyra Therapeutics Revenue Estimates

Aldeyra Therapeutics EBITDA Estimates

Aldeyra Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $32.69M
Low: $17.17M
High: $61.79M
avg. 0%
Avg: $74.63M
Low: $65.33M
High: $92.08M
avg. 128.26%
Avg: $113.90M
Low: $99.69M
High: $140.51M
avg. 52.60%
Avg: $174.40M
Low: $152.65M
High: $215.16M
avg. 53.11%
Net Income
 
% change YoY
$-59.25M
 
N/A
$-61.36M
 
-3.56%
$-37.54M
 
38.82%
Avg: $-29.86M
Low: $-53.04M
High: $26.52M
avg. 20.45%
Avg: $12.24M
Low: $-33.00M
High: $76.62M
avg. 141.01%
Avg: $30.84M
Low: $25.84M
High: $40.21M
avg. 151.82%
Avg: $70.53M
Low: $59.10M
High: $91.96M
avg. 128.66%
EBITDA
 
% change YoY
$-56.03M
 
N/A
$-60.33M
 
-7.66%
$-35.20M
 
41.64%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$1.1
 
N/A
-$1.05
 
4.54%
-$0.64
 
39.04%
Avg: -$0.49
Low: -$0.9
High: $0.45
avg. 23.69%
Avg: $0.22
Low: -$0.56
High: $1.3
avg. 144.02%
Avg: $0.52
Low: $0.44
High: $0.68
avg. 143.40%
Avg: $1.2
Low: $1
High: $1.56
avg. 128.66%
Operating Expenses
 
% change YoY
$56.21M
 
N/A
$62.67M
 
11.49%
$42.79M
 
-31.72%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Aldeyra Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 110.49% in 2025-2028.

We have gathered data from 5 analysts. Their low estimate is -53.04M, average is -29.86M and high is 26.52M.

What is Aldeyra Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 58.49% in 2025-2028.

We have gathered data from 5 analysts. Their low revenue estimate is $17.17M, average is $32.69M and high is $61.79M.

What is Aldeyra Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 109.94% in 2025-2028.

We have gathered data from 5 analysts. Their low earnings per share estimate is -$0.9, average is -$0.49 and high is $0.45.

What is the best performing analyst?

In the last twelve months analysts have been covering Aldeyra Therapeutics stock. The most successful analyst is Justin Kim.